Journal of General Virology, Vol 79, 731-740, Copyright © 1998 by Society for General Microbiology

ARTICLES

Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression

M Wachinger, A Kleinschmidt, D Winder, N von Pechmann, A Ludvigsen, M Neumann, R Holle, B Salmons, V Erfle and R Brack-Werner
Institute of Molecular Virology, GSF-National Research Center for Environment and Health, Neuherberg, Germany.

Antimicrobial peptides are effectors of innate immunity, providing their hosts with rapid non-specific defence against parasitic invaders. In this report, the effects are assessed of two well-characterized antimicrobial amphipathic peptides (melittin and cecropin) on human immunodeficiency virus 1 (HIV-1) replication and gene expression in acutely infected cells at subtoxic concentrations. Production of infectious, cell-free virus was inhibited in a dose-dependent manner, with ID50 values in the range 0.9-1.5 microM for melittin and 2-3 microM for cecropin. Analysis of the effect of melittin on cell- associated virus production revealed decreased levels of Gag antigen and HIV-1 mRNAs. Transient transfection assays with HIV long terminal repeat (LTR)-driven reporter gene plasmids indicated that melittin has a direct suppressive effect on activity of the HIV LTR. HIV LTR activity was also reduced in human cells stably transfected with retroviral expression plasmids for the melittin or cecropin gene. It is concluded that antimicrobial peptides such as melittin and cecropin are capable of inhibiting cell-associated production of HIV-1 by suppressing HIV-1 gene expression.

This article has been cited by other articles:

				G. Wang, K. M. Watson, and R. W. Buckheit Jr. Anti-Human Immunodeficiency Virus Type 1 Activities of Antimicrobial Peptides Derived from Human and Bovine Cathelicidins Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3438 - 3440. [Abstract] [Full Text] [PDF]

				F. Groot, T. M. M. van Capel, M. L. Kapsenberg, B. Berkhout, and E. C. de Jong Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition Blood, September 15, 2006; 108(6): 1957 - 1964. [Abstract] [Full Text] [PDF]

				F. Groot, R. W. Sanders, O. ter Brake, K. Nazmi, E. C. I. Veerman, J. G. M. Bolscher, and B. Berkhout Histatin 5-derived Peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry. J. Virol., September 1, 2006; 80(18): 9236 - 9243. [Abstract] [Full Text] [PDF]

				H. Jenssen, P. Hamill, and R. E. W. Hancock Peptide Antimicrobial Agents Clin. Microbiol. Rev., July 1, 2006; 19(3): 491 - 511. [Abstract] [Full Text] [PDF]

				M. L. Mangoni, J. M. Saugar, M. Dellisanti, D. Barra, M. Simmaco, and L. Rivas Temporins, Small Antimicrobial Peptides with Leishmanicidal Activity J. Biol. Chem., January 14, 2005; 280(2): 984 - 990. [Abstract] [Full Text] [PDF]

				H. Tanabe, A. J. Ouellette, M. J. Cocco, and W. E. Robinson Jr. Differential Effects on Human Immunodeficiency Virus Type 1 Replication by {alpha}-Defensins with Comparable Bactericidal Activities J. Virol., November 1, 2004; 78(21): 11622 - 11631. [Abstract] [Full Text] [PDF]

				P. Roch, A. Beschin, and E. Bernard Antiprotozoan and Antiviral Activities of Non-cytotoxic Truncated and Variant Analogues of Mussel Defensin Evid. Based Complement. Altern. Med., September 1, 2004; 1(2): 167 - 174. [Abstract] [Full Text] [PDF]

				L. Zhang, W. Yu, T. He, J. Yu, R. E. Caffrey, E. A. Dalmasso, S. Fu, T. Pham, J. Mei, J. J. Ho, et al. Contribution of Human alpha -Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor Science, November 1, 2002; 298(5595): 995 - 1000. [Abstract] [Full Text] [PDF]

				J. Ma, S. Kennedy-Stoskopf, J. M. Jaynes, L. M. Thurmond, and W. A. Tompkins Inhibitory Activity of Synthetic Peptide Antibiotics on Feline Immunodeficiency Virus Infectivity In Vitro J. Virol., August 28, 2002; 76(19): 9952 - 9961. [Abstract] [Full Text] [PDF]

				C. A. Brissette and S. A. Lukehart Treponema denticola Is Resistant to Human {beta}-Defensins Infect. Immun., July 1, 2002; 70(7): 3982 - 3984. [Abstract] [Full Text] [PDF]

				L. Kuhn-Nentwig, J. Muller, J. Schaller, A. Walz, M. Dathe, and W. Nentwig Cupiennin 1, a New Family of Highly Basic Antimicrobial Peptides in the Venom of the Spider Cupiennius salei (Ctenidae) J. Biol. Chem., March 22, 2002; 277(13): 11208 - 11216. [Abstract] [Full Text] [PDF]

				L. M. Ballweber, J. E. Jaynes, W. E. Stamm, and M. F. Lampe In Vitro Microbicidal Activities of Cecropin Peptides D2A21 and D4E1 and Gel Formulations Containing 0.1 to 2% D2A21 against Chlamydia trachomatis Antimicrob. Agents Chemother., January 1, 2002; 46(1): 34 - 41. [Abstract] [Full Text] [PDF]

				H. Oh, M. Hedberg, D. Wade, and C. Edlund Activities of Synthetic Hybrid Peptides against Anaerobic Bacteria: Aspects of Methodology and Stability Antimicrob. Agents Chemother., January 1, 2000; 44(1): 68 - 72. [Abstract] [Full Text]